LEDIFOS (LEDIPASVIR 90 MG & SOFOSBUVIR 400 MG TABLETS)
Ledifos (Ledipasvir 90 mg & sofosbuvir 400 mg Tablets). Hetero Healthcare Ltd. got approval on 8th Dec 2015 by Drug Controller General of India (DCGI).
Ledipasvir +Sofosbuvir is a two-drug fixed-dose combination product that contains 90 mg of ledipasvir and 400 mg of sofosbuvir in a single tablet. It is indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults.
Ledifos (Ledipasvir) Tablets suppliers in India. Allevaire India Network New Delhi, INDIA.
Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.
SOURCING:
Alleviare Life Sciences connects the buyer with the supplier who can ship Ledifos Ledipasvir (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. LEDIFOS is manufactured by Hetero Healthcare Ltd.
Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
The order for Ledifos (Ledipasvir) Tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Comments
Post a Comment